首页> 外文期刊>The journal of ECT >Safety of repeated transcranial direct current stimulation in impaired skin a case report
【24h】

Safety of repeated transcranial direct current stimulation in impaired skin a case report

机译:反复经颅直流电刺激在受损皮肤中的安全性一例报告

获取原文
获取原文并翻译 | 示例
           

摘要

Transcranial direct current stimulation (tDCS) is a neuromodulatory technique based on the application of a weak, direct electric current via 2 or more electrodes (anode and cathode) over the scalp. One concern when applying tDCS is skin burn. It has been suggested that skin lesions are related to changes in the local dermal homeostasis, and therefore, caution is warranted in patients with skin diseases (Loo et al [Int J Neuropsychopharmacol. 2011;14:425Y426]). In this context, we believe that it would be useful for this emerging field of tDCS to report the preliminary safety of repeated application of tDCS in a patient with vitiligo, an autoimmune disorder characterized by depigmentation sites of the skin or mucous membranes. We report the case of a 31-year-old male patient with schizophrenia who underwent 10-daily tDCS sessions. He has had generalized vitiligo since childhood, and despite previous treatment, no current dermatologic followup was being carried out. Depigmentation sites were evident in different areas, particularly under the anodal area. We found that repeated anodal tDCS in 1 patient did not lead to skin lesions when applied over a vitiligo skin area. Some of the procedures that we used to buffer changes in skin temperature may have contributed to prevent tDCS-induced skin damage. Nevertheless, the exact conditions that lead to skin lesion are still unknown. Given the growing use and testing of tDCS, continuous assessment and reporting of local adverse effects are still warranted especially in conditions with increased risk of skin lesions such as in dermatologic conditions, skin burns, and previous skin damage.
机译:经颅直流电刺激(tDCS)是一种神经调节技术,基于通过头皮上2个或多个电极(阳极和阴极)施加微弱的直流电流的技术。应用tDCS时需要关注的一个问题是皮肤灼伤。已经提出皮肤损伤与局部皮肤动态平衡的变化有关,因此,在患有皮肤疾病的患者中应谨慎(Loo等人[Int J Neuropsychopharmacol.2011; 14:425Y426])。在这种情况下,我们认为报告tDCS在白癜风患者中反复应用tDCS的初步安全性是有用的,白癜风是一种以皮肤或粘膜的色素沉着部位为特征的自身免疫性疾病。我们报告了一位每天接受10天tDCS治疗的精神分裂症的31岁男性患者的病例。他从小就开始泛白癜风,尽管有过先前的治疗,但目前尚无皮肤病学随访。在不同区域,特别是在阳极区域,色素沉着部位明显。我们发现,在1名患者中重复使用阳极tDCS并在白癜风皮肤区域上使用不会导致皮肤损伤。我们用来缓冲皮肤温度变化的某些程序可能有助于防止tDCS引起的皮肤损伤。尽管如此,导致皮肤病变的确切条件仍然未知。鉴于tDCS的使用和测试越来越多,仍需要对局部不良反应进行连续评估和报告,尤其是在皮肤病变风险增加的情况下,例如在皮肤病,皮肤灼伤和先前的​​皮肤损伤中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号